Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RAPIDA: Adalimumab in Luminal Crohn's Disease
NCT02148718Phase 4Completed
- Sponsor
- AbbVie Inc.
- Start
- Jun 2014
- Primary completion
- Aug 2016
- Modality
- Monoclonal Antibodies
01
Overview
A Phase 4 trial of adalimumab in Crohn's disease, sponsored by AbbVie Inc.. Started Jun 2014; status: completed.
02
Drugs
03
Conditions
Crohn's disease
Beyond the preview
Go deeper on NCT02148718.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02148718.